Table 4. Proportion of drug resistance in new tuberculosis cases tested in 11 Chinese provinces.

Province	Method of data collection	Number of patients tested	Any resistance	Resistance to rifampin	Multidrug resistance (MDR) †
North region in China
Jilin	SVY*	1174	32.3%	10.6%	8.6%
Heilongjiang	SVY	1574	36.1%	10.6%	7.2%
Liaoning	SVY	818	42.1%	11.4%	10.3%
Inner Mongolia	SVY	806	35.0%	9.8%	7.3%
Beijing	SVY	1043	17.9%	4.2%	2.3%
Henan	SVY	646	35.0%	14.6%	10.9%
Shandong	SVY	1009	17.6%	3.8%	2.9%
South region in China
Shanghai	SVY	764	15.4%	4.8%	3.9%
Zhejiang	SVY	809	14.8%	6.4%	4.4%
Guangdong	SVY	1432	18.0%	7.1%	5.4%
Hubei	SVY	859	17.5%	3.8%	2.0%
China ‡	SVY	3037	34.2%	6.7%	5.7%

*SYV: drug resistance survey.

^† Multidrug-resistant TB is tuberculosis with resistance to both isoniazid and rifampin.

^‡The data is cited from National Drug resistance Survey of China.